CIK 0001850902
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Alpha Teknova, Inc.
Sign in to watch- Ticker
- TKNO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943368109
- Phone
- +1 831-637-1100
- Business address
- 2451 BERT DRIVE, HOLLISTER, CA, 95023
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-06 | Lowell Matthew Chief Financial Officer | Purchase | +40,000 | $2.19 | $88K | 168,376 |
| 2026-02-15 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +171,000 | 171,000 | ||
| 2025-02-14 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +169,857 | 169,857 | ||
| 2024-07-12 | Lowell Matthew Chief Financial Officer | Purchase | +40,322 | $1.24 | $50K | 128,376 |
| 2023-09-19 | Lowell Matthew Chief Financial Officer | Purchase | +54,054 | $1.85 | $100K | 88,054 |
| 2023-02-27 | Lowell Matthew Chief Financial Officer | Grant or award | +14,000 | 34,000 | ||
| 2023-02-27 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2022-11-15 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +33,093 | 33,093 | ||
| 2022-09-01 | Lowell Matthew Chief Financial Officer | Purchase | +10,000 | $4.61 | $46K | 20,000 |
| 2022-05-20 | Lowell Matthew Chief Financial Officer | Purchase | +10,000 | $9.45 | $94K | 10,000 |
| 2022-02-15 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-06-24 | Lowell Matthew Chief Financial Officer | Grant or award · Stock Option (Right to buy) | +6,186 | 6,186 |
Page 1 of 1 · 12 trades